Crotalaria burhia
Crotalaria burhia · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Crotalaria burhia is a botanical species recognized for its diverse pharmacological potential, particularly through its antioxidant and analgesic activities. Research focusing on its roots and aerial parts has identified key bioactive compounds, including flavonoids, saponins, 3-OH-4-MeO benzaldehyde, and 4-OH benzoic acid. Various preparations, such as methanol and dichloromethane (DCM) extracts of both the roots and aerial parts, are utilized to study these medicinal properties. These extracts show promise in addressing complex biological conditions, including cancer, hydrophobia, infections, and pain. Consequently, this plant serves as a significant subject for investigating natural therapeutic agents.
- Synonyms
- Crotalaria Arida
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Northern America
- Plant Parts
- Root
Classification
Synonyms
Crotalaria burhia is a plant species that is frequently identified by its alternative taxonomic name. Within botanical literature, it is recognized as having the synonym Crotalaria arida. This dual nomenclature can sometimes cause confusion for researchers navigating various scientific databases. However, understanding these linguistic links is essential for maintaining accurate classification and records. Recognizing both names ensures that botanists can consistently track the plant's distribution and characteristics.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Crotalaria burhia is a fascinating botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, the plant is classified under the class Equisetopsida. It further descends through the order Fabales, showcasing its specific evolutionary lineage. As a member of the family Fabaceae, it shares important characteristics with other legumes. Finally, this species is formally identified by its distinct genus, Crotalaria.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Crotalaria |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Crotalaria burhia exhibits a wide geographical range that spans both temperate and tropical regions of Asia. In the more temperate zones, the plant is distributed across Western Asia, specifically found within Afghanistan and Iran. Its presence extends significantly into the tropical landscapes of the Indian Subcontinent. Within these warmer climates, the species is commonly established in both India and Pakistan. This diverse distribution highlights the plant's ability to adapt to varying environmental conditions across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Crotalaria burhia is a significant medicinal plant widely distributed across arid regions such as India, Pakistan, and Afghanistan. Scientific investigations have confirmed that this species possesses notable antioxidant activity, particularly within its methanol extracts. Specifically, the root and aerial parts have demonstrated high efficacy in various assays, including DPPH, ABTS, and FRAP. In addition to these properties, the plant is recognized for its analgesic and anti-inflammatory potential, making it valuable for treating pain and swelling. These diverse pharmacological activities suggest that C. burhia is a promising natural source of bioactive compounds for therapeutic use.
Compounds
Crotalaria burhia serves as a rich source of diverse bioactive compounds, as demonstrated through comprehensive phytochemical analyses. Scientific investigations have identified several key constituents within the plant, including 3-OH-4-MeO benzaldehyde and 4-OH benzoic acid. The plant's chemical profile also features significant amounts of carvacrol, which contributes to its medicinal potential. Furthermore, the presence of polyphenols such as catechin and epicatechin highlights its valuable antioxidant properties. These findings suggest that the plant is a promising candidate for developing various therapeutic applications.
Conditions
Crotalaria burhia demonstrates significant antioxidant activity by treating ABTS through its aerial-methanol extract. The plant also exhibits strong antioxidant properties by treating CUPRAC and DPPH, particularly within its root-methanol extract. Additionally, the plant shows potential for enzyme inhibition by treating acetylcholinesterase (AChE) via its aerial-DCM extract. These diverse biological interactions highlight the plant's multifaceted therapeutic capabilities.
Preparations
Crotalaria burhia is prepared as aerial-DCM extract and aerial-methanol extract to evaluate various biological potentials. The plant is also processed as methanol and dichloromethane (DCM) extracts of both aerial and root parts for comprehensive phytochemical analysis. Additionally, the species is prepared as methanolic extracts from the roots and aerial parts to identify key phytoconstituents. Finally, Crotalaria burhia is prepared as a root-methanol extract, which has been shown to contain high levels of phenolics and flavonoids.
Parts used
Crotalaria burhia is a significant medicinal plant that possesses distinct bioactive properties within its various anatomical structures. Research indicates that the plant contains both aerial parts and roots, each offering unique phytochemical profiles. Specifically, the root part serves as a potent source of secondary metabolites, yielding the highest concentrations of phenolics and flavonoids. These root extracts also demonstrated superior performance in antioxidant assays such as DPPH and CUPRAC. Consequently, the specialized components found in the roots contribute to the plant's overall potential for diverse therapeutic applications.